loader image
Wednesday, January 21, 2026
67.3 F
McAllen
- Advertisement -

LEARN MORE ABOUT DR. BILAL BIN HAFEEZ

Community NewsNews
1303

Translate to Spanish or other 102 languages!

Graduate research assistants Emmanuel Anning, Godwin Peasah-Darkwah and Asif Shahriar work in the lab to assist in the development of a treatment for advanced pancreatic cancer. (UTRGV Image Office of Research & New Program Development)

Mega Doctor News

- Advertisement -

Hafeez is the founding member of the first nationally recognized South Texas Center of Excellence in Cancer Immunology at the UTRGV School of Medicine and is an accomplished researcher with a background in immunopharmacology, cancer therapeutics and cancer biology. Hafeez, a Nehtaur, Bijnor, Uttar Pradesh, India native, has earned prestigious grant awards and is an active member of the American Association for Cancer Research and the Indian Association for Cancer Research. His significant contributions to cancer biology and molecular therapeutics have led to his numerous published manuscripts in scientific journals. 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
School of Medicine earns $1.45M grant for pancreatic cancer research
Next article
Nursing and Allied Health to host new conference dedicated to health careers for students

More Articles

Explore Career Opportunities at STHS’ All‑Facilities Hiring Event, Jan. 28th 

From the registered nurses across a variety of specialties who deliver quality, compassionate care to patients to the dedicated support staff who ensure South Texas Health System’s (STHS) facilities operate efficiently and effectively, it takes a village of exceptional healthcare professionals to maintain STHS’ status as a nationally recognized healthcare leader.

Immune‑Driven Vaccine Advances Cancer Prevention Research

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University of Texas MD Anderson Cancer Center.

Dr. Pedro Mego: Saving Limbs by Uncovering a Silent Vascular Threat

Mega Doctor News In South Texas, a quiet crisis is unfolding—one that...

Dr. Pedro Mego on Preventing Amputation Through Early Detection 

Dr. Pedro Mego, FSCAI, is a board-certified Interventional Cardiologist. He said his decision to dedicate his medical practice entirely to peripheral artery and venous disease was shaped by what he encountered after arriving in South Texas.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×